Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Alkem Laboratories Limited
Established in 1973, Alkem Laboratories Limited has 53 years of operational experience. The company’s Corporate Identification Number is L00305MH1973PLC174201; registration no. 174201. It belongs to the classification of company limited by shares as per MCA records. Authorized capital of the company is recorded at ₹50.00 crore. The total paid-up share capital is ₹23.91 crore.
This entity is registered in Mumbai, India. The firm’s incorporation address reads Alkem House, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India, 400013. Alkem Laboratories Limited remains active and operational. PAN number for the company is AABCA9521E. The company has been issued the Legal Entity Identifier code 335800GCAE5WIF4PSG69. The company’s official contact email is investors@alkem.com. Alkem Laboratories Limited’s leadership roster features Nitin Agrawal (CFO) and Vikas Gupta (CEO).
Company Overview
- CIN
- Date of Incorporation
- 07/08/1973
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹50,00,00,000.00
- Paid up Capital
- ₹23,91,30,000.00
- Activity
- -
- investors@alkem.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Assam | 18AABCA9521E2ZV | Inactive |
| 18AABCA9521E1ZW | Active | |
| Andhra Pradesh | 37AABCA9521E1ZW | Active |
| Bihar | 10AABCA9521E2ZB | Inactive |
| 10AABCA9521E1ZC | Active | |
| 10AABCA9521E3ZA | Inactive | |
| Chhattisgarh | 22AABCA9521E1Z7 | Active |
| Delhi | 07AABCA9521E1ZZ | Active |
| Daman and Diu | 25AABCA9521E1Z1 | Inactive |
| Dadra and Nagar Haveli and Daman and Diu | 26AABCA9521E1ZZ | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE540L01014 | ALKEM LABORATORIES LIMITED EQ | - | 12/10/2026 | ALKEM LAB/SH VTG | ESVUFN |
| IN8540L01013 | ALKEM LABORATORIES LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | ALKEM LAB/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net PPE | ₹3,34,563.00L | ₹2,93,187.00L | ₹2,59,551.00L | ₹2,51,355.00L |
| Net Debt | ₹1,37,559.00L | ₹75,865.00L | ₹75,890.00L | ₹1,03,335.00L |
| Goodwill | ₹52,364.00L | ₹42,311.00L | ₹41,674.00L | ₹41,317.00L |
| Gross PPE | ₹5,28,431.00L | ₹4,60,226.00L | ₹3,97,285.00L | ₹3,63,463.00L |
| Inventory | ₹3,33,322.00L | ₹2,92,241.00L | ₹2,66,118.00L | ₹2,60,753.00L |
| Total Debt | ₹2,04,716.00L | ₹1,38,090.00L | ₹1,41,841.00L | ₹1,39,668.00L |
| Common Stock | ₹2,391.00L | ₹2,391.00L | ₹2,391.00L | ₹2,391.00L |
| Current Debt | ₹1,13,105.00L | ₹75,188.00L | ₹1,17,397.00L | ₹1,30,715.00L |
| Share Issued | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L |
| Total Assets | ₹20,87,297.00L | ₹17,69,110.00L | ₹15,57,490.00L | ₹13,75,665.00L |
| Capital Stock | ₹2,391.00L | ₹2,391.00L | ₹2,391.00L | ₹2,391.00L |
| Long Term Debt | ₹49,245.00L | ₹31,091.00L | ₹4,000.00L | ₹0.00L |
| Current Assets | ₹12,21,052.00L | ₹10,94,582.00L | ₹10,41,158.00L | ₹8,72,968.00L |
| Prepaid Assets | ₹84,790.00L | ₹77,422.00L | ₹77,843.00L | ₹71,349.00L |
| Working Capital | ₹7,42,782.00L | ₹6,97,886.00L | ₹6,41,703.00L | ₹5,02,254.00L |
| Invested Capital | ₹15,44,360.00L | ₹13,04,766.00L | ₹11,52,603.00L | ₹10,35,244.00L |
| Other Properties | ₹3,09,063.00L | ₹2,38,615.00L | ₹24,717.00L | ₹13,786.00L |
| Retained Earnings | ₹11,66,230.00L | ₹9,97,301.00L | ₹8,30,970.00L | ₹7,05,197.00L |
| Common Stock Equity | ₹13,82,010.00L | ₹11,98,487.00L | ₹10,31,206.00L | ₹9,04,529.00L |
| Net Tangible Assets | ₹12,89,582.00L | ₹11,44,719.00L | ₹9,83,774.00L | ₹8,55,274.00L |
| Tangible Book Value | ₹12,89,582.00L | ₹11,44,719.00L | ₹9,83,774.00L | ₹8,55,274.00L |
| Current Liabilities | ₹4,78,270.00L | ₹3,96,696.00L | ₹3,99,455.00L | ₹3,70,714.00L |
| Long Term Provisions | ₹43,121.00L | ₹33,822.00L | ₹29,986.00L | ₹36,936.00L |
| Stockholders Equity | ₹13,82,010.00L | ₹11,98,487.00L | ₹10,31,206.00L | ₹9,04,529.00L |
| Other Equity Interest | ₹3,554.00L | ₹3,616.00L | ₹1,954.00L | ₹60.00L |
| Total Capitalization | ₹14,31,255.00L | ₹12,29,578.00L | ₹10,35,206.00L | ₹9,04,529.00L |
| Ordinary Shares Number | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L |
| Other Intangible Assets | ₹40,064.00L | ₹11,457.00L | ₹5,758.00L | ₹7,938.00L |
| Other Non Current Assets | ₹26,308.00L | -₹3.00L | -₹1.00L | -₹1.00L |
| Total Non Current Assets | ₹8,66,245.00L | ₹6,74,528.00L | ₹5,16,332.00L | ₹5,02,697.00L |
| Cash And Cash Equivalents | ₹24,791.00L | ₹30,414.00L | ₹45,507.00L | ₹27,380.00L |
| Construction In Progress | ₹25,500.00L | ₹54,569.00L | ₹18,687.00L | ₹31,027.00L |
| Accumulated Depreciation | -₹1,93,868.00L | -₹1,67,039.00L | -₹1,37,734.00L | -₹1,12,108.00L |
| Other Short Term Investments | ₹3,81,729.00L | ₹3,47,378.00L | ₹3,81,465.00L | ₹86,936.00L |
| Other Non Current Liabilities | ₹1,808.00L | ₹2,195.00L | ₹2,584.00L | ₹1.00L |
| Machinery Furniture Equipment | ₹2,94,712.00L | ₹2,48,480.00L | ₹2,36,904.00L | ₹2,17,099.00L |
| Derivative Product Liabilities | ₹26,145.00L | ₹22,442.00L | ₹19,656.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹92,428.00L | ₹53,768.00L | ₹47,432.00L | ₹49,255.00L |
| Total Equity Gross Minority Interest | ₹14,34,893.00L | ₹12,43,363.00L | ₹10,71,440.00L | ₹9,43,500.00L |
| Total Liabilities Net Minority Interest | ₹6,52,404.00L | ₹5,25,747.00L | ₹4,86,050.00L | ₹4,32,165.00L |
| Current Debt And Capital Lease Obligation | ₹1,17,793.00L | ₹80,257.00L | ₹1,18,915.00L | ₹1,32,635.00L |
| Long Term Debt And Capital Lease Obligation | ₹86,923.00L | ₹57,833.00L | ₹22,926.00L | ₹7,033.00L |
| Cash Cash Equivalents And Short Term Investments | ₹4,06,520.00L | ₹3,77,792.00L | ₹4,26,972.00L | ₹1,14,316.00L |
| Total Non Current Liabilities Net Minority Interest | ₹1,74,134.00L | ₹1,29,051.00L | ₹86,595.00L | ₹61,451.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L | ₹0.00L |
| Free Cash Flow | ₹1,34,577.00L | ₹1,23,722.00L | ₹1,68,878.00L | ₹1,44,959.00L | ₹0.00L |
| Changes In Cash | -₹20,758.00L | -₹19,691.00L | -₹20,544.00L | ₹3,452.00L | ₹0.00L |
| End Cash Position | -₹34,213.00L | -₹12,009.00L | ₹6,631.00L | ₹27,380.00L | ₹0.00L |
| Financing Cash Flow | -₹50,340.00L | -₹81,099.00L | -₹1,14,501.00L | -₹1,76,082.00L | ₹0.00L |
| Investing Cash Flow | -₹1,66,721.00L | -₹1,29,876.00L | -₹1,00,850.00L | ₹11,284.00L | ₹0.00L |
| Operating Cash Flow | ₹1,96,303.00L | ₹1,91,284.00L | ₹1,94,807.00L | ₹1,68,250.00L | ₹0.00L |
| Capital Expenditure | -₹61,726.00L | -₹67,562.00L | -₹25,929.00L | -₹23,291.00L | ₹0.00L |
| Beginning Cash Position | -₹12,009.00L | ₹6,631.00L | ₹27,380.00L | ₹23,218.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹2,98,686.00L | ₹2,61,427.00L | ₹2,11,884.00L | ₹1,39,852.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹3,36,892.00L | ₹2,97,143.00L | ₹2,41,814.00L | ₹1,70,894.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹9,33,300.00L | ₹7,94,707.00L | ₹7,40,747.00L | ₹6,45,803.00L |
| Pretax Income | ₹2,87,089.00L | ₹2,52,703.00L | ₹2,02,313.00L | ₹1,30,477.00L |
| Tax Provision | ₹51,776.00L | ₹31,103.00L | ₹21,167.00L | ₹29,796.00L |
| Total Revenue | ₹14,53,234.00L | ₹12,80,462.00L | ₹12,43,924.00L | ₹11,44,035.00L |
| Cost Of Revenue | ₹5,19,934.00L | ₹4,85,755.00L | ₹5,03,177.00L | ₹4,98,232.00L |
| Total Expenses | ₹11,88,321.00L | ₹10,62,039.00L | ₹10,45,438.00L | ₹10,10,618.00L |
| Interest Income | ₹39,164.00L | ₹35,878.00L | ₹27,577.00L | ₹17,114.00L |
| Interest Expense | ₹11,597.00L | ₹8,724.00L | ₹9,571.00L | ₹9,375.00L |
| Operating Income | ₹2,64,913.00L | ₹2,18,423.00L | ₹1,98,486.00L | ₹1,33,417.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹3,49,147.00L | ₹2,92,767.00L | ₹2,52,764.00L | ₹1,79,559.00L |
| Normalized Income | ₹2,40,229.10L | ₹2,12,710.60L | ₹1,89,377.25L | ₹1,05,106.38L |
| Operating Expense | ₹6,68,387.00L | ₹5,76,284.00L | ₹5,42,261.00L | ₹5,12,386.00L |
| Operating Revenue | ₹14,53,234.00L | ₹12,80,462.00L | ₹12,43,924.00L | ₹11,44,035.00L |
| Net Interest Income | ₹23,086.00L | ₹23,708.00L | ₹16,336.00L | ₹6,378.00L |
| Total Unusual Items | -₹12,255.00L | ₹4,376.00L | -₹10,950.00L | -₹8,665.00L |
| Basic Average Shares | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L |
| Diluted Average Shares | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L | ₹1,195.65L |
| Total Other Finance Cost | ₹4,481.00L | ₹3,446.00L | ₹1,670.00L | ₹1,361.00L |
| Other Operating Expenses | ₹1,49,498.00L | ₹1,34,895.00L | ₹1,42,413.00L | ₹1,10,624.00L |
| Reconciled Depreciation | ₹38,206.00L | ₹35,716.00L | ₹29,930.00L | ₹31,042.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹5,19,934.00L | ₹4,85,755.00L | ₹5,03,177.00L | ₹4,98,232.00L |
| Rent Expense Supplemental | ₹1,098.00L | ₹1,008.00L | ₹960.00L | ₹978.00L |
| Tax Effect Of Unusual Items | -₹2,205.90L | ₹538.60L | -₹1,149.75L | -₹1,975.62L |
| Interest Income Non Operating | ₹39,164.00L | ₹35,878.00L | ₹27,577.00L | ₹17,114.00L |
| Selling And Marketing Expense | ₹1,52,087.00L | ₹1,29,313.00L | ₹1,28,187.00L | ₹1,31,508.00L |
| Interest Expense Non Operating | ₹11,597.00L | ₹8,724.00L | ₹9,571.00L | ₹9,375.00L |
| Net Income Common Stockholders | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L |
| Net Income Continuous Operations | ₹2,35,116.00L | ₹2,21,538.00L | ₹1,81,146.00L | ₹1,00,681.00L |
| Diluted NIAvailto Com Stockholders | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L |
| General And Administrative Expense | ₹44,939.00L | ₹31,698.00L | ₹30,290.00L | ₹29,914.00L |
| Selling General And Administration | ₹1,97,026.00L | ₹1,61,011.00L | ₹1,58,477.00L | ₹1,61,422.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹12,255.00L | ₹4,376.00L | -₹10,950.00L | -₹8,665.00L |
| Net Non Operating Interest Income Expense | ₹23,086.00L | ₹23,708.00L | ₹16,336.00L | ₹6,378.00L |
| Net Income Including Noncontrolling Interests | ₹2,35,116.00L | ₹2,21,538.00L | ₹1,81,146.00L | ₹1,00,681.00L |
| Net Income From Continuing And Discontinued Operation | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹2,30,180.00L | ₹2,16,548.00L | ₹1,79,577.00L | ₹98,417.00L |
Company Performance (FY23–FY26)
₹14.5 K Cr₹10.9 K Cr₹7.3 K Cr₹3.6 K Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 08/08/1973 | Basudeo Narayan Singh | 00760310 | Whole-time director | View other directorships |
| 16/12/2006 | Manish Narang | *****6263D | Company Secretary | |
| 11/02/2008 | Mritunjay Kumar Singh | 00881412 | Whole-time director | View other directorships |
| 09/08/2013 | Sandeep Singh | 01277984 | Managing Director | View other directorships |
| 16/03/2015 | Arun Kumar Purwar | 00026383 | Director | View other directorships |
| 29/06/2015 | Sangeeta Kapil Jit Singh | 06920906 | Director | View other directorships |
| 29/06/2015 | Sudha Ravi | 06764496 | Director | View other directorships |
| 11/11/2019 | Sarvesh Singh | 01278229 | Whole-time director | View other directorships |
| 16/03/2020 | Narendra Kumar Aneja | 00124302 | Director | View other directorships |
| 20/12/2021 | Madhurima Singh | 09137323 | Whole-time director | View other directorships |
| 05/08/2022 | Sujjain Suresh Talwar | 01756539 | Director | View other directorships |
| 14/09/2022 | Srinivas Balmiki Prasad Singh | 06744441 | Whole-time director | View other directorships |
| 22/09/2023 | Vikas Gupta | *****8248K | CEO | |
| 01/02/2024 | Nitin Agrawal | *****9161G | CFO | |
| 09/08/2024 | Rajeev Kher | 01192524 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 15
- Sandeep SinghManaging Director
- Srinivas Balmiki Prasad SinghWhole-time director
- Madhurima SinghWhole-time director
- Sarvesh SinghWhole-time director
- Mritunjay Kumar SinghWhole-time director
- Basudeo Narayan SinghWhole-time director
- Rajeev KherDirector
- Sujjain Suresh TalwarDirector
- Narendra Kumar AnejaDirector
- Sangeeta Kapil Jit SinghDirector
- Sudha RaviDirector
- Arun Kumar PurwarDirector
- Nitin AgrawalCFO
- Vikas GuptaCEO
- Manish NarangCompany Secretary
Subsidiaries 8
- Indchemie Health Specialities Private LimitedDirect
- Adroit Biomed LimitedDirect
- Ascend Laboratories, LlcDirect
- Товарищество С Ограниченной Ответственностью "the Pharmа Network"Direct
- Ascend Laboratories SpaDirect
- S&b Pharma LlcDirect
- The Pharma Network, LlcDirect
- Enzene Biosciences LimitedDirect
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/12/2024 | Form Addendum to AOC-4 CSR-27112024 | - |
| 28/10/2024 | Form MGT-7-28102024 | - |
| 28/09/2024 | Form AOC-4(XBRL)-28092024 | - |
| 30/03/2024 | Form Addendum to AOC-4 CSR-30032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Pan Electronics (india) Limited | L00309KA1982PLC004960 | 16b, 1st Phase, Peenya Industrial Area Peenya, Bangalore, Bangalore, Karnataka, India, 560058 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Indchemie Health Specialities Private Limited | 335800UL6P5E2BR4Y384 |
| Direct | Adroit Biomed Limited | 894500VEXNTRT169HM92 |
| Direct | Ascend Laboratories, Llc | 98450039B8ED4EFDCE96 |
| Direct | Товарищество С Ограниченной Ответственностью "the Pharmа Network" | 9845008B054455BE4596 |
| Direct | Ascend Laboratories Spa | 9845009DFE6A5CCED408 |
| Direct | S&b Pharma Llc | 984500B0F30P70443993 |
| Direct | The Pharma Network, Llc | 984500C7GA499FCE1E18 |
| Direct | Enzene Biosciences Limited | 984500EG36E1F657CC98 |
Address
Alkem House, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India, 400013
Frequently Asked Questions
What is the incorporation date of Alkem Laboratories Limited?
The incorporation date of Alkem Laboratories Limited is 07/08/1973.
What is the authorized share capital and paid-up capital of Alkem Laboratories Limited?
The authorized share capital of Alkem Laboratories Limited is ₹50,00,00,000.00. The paid-up capital is ₹23,91,30,000.00.
Who are the current board members & directors of Alkem Laboratories Limited?
The current board member of Alkem Laboratories Limited are:
- Basudeo Narayan Singh
- Narendra Kumar Aneja
- Mritunjay Kumar Singh
- Sarvesh Singh
- Sandeep Singh
- Sujjain Suresh Talwar
- Srinivas Balmiki Prasad Singh
- Sangeeta Kapil Jit Singh
- Arun Kumar Purwar
- Sudha Ravi
- Madhurima Singh
- Rajeev Kher
What is the registered address of Alkem Laboratories Limited?
The registered address of Alkem Laboratories Limited is Alkem House, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India, 400013.
What is the Corporate Identification Number of Alkem Laboratories Limited?
The Corporate Identification Number of Alkem Laboratories Limited is L00305MH1973PLC174201.